I wouldn’t touch RAD. Assets are very early stage and undifferentiated. TLX now commercial with Illuccix in Oz and FDA 1 month away. That’s the biggest trigger for any biotech. TLX has exceptional management and board. Superb execution so far. Deep pipeline they keep topping up.
Radiopharm - anyone know how this compares to TLX?, page-7
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.81 |
Change
0.490(2.54%) |
Mkt cap ! $6.629B | |||
| Open | High | Low | Value | Volume |
| $19.49 | $19.81 | $19.28 | $27.96M | 1.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150 | $19.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.81 | 10432 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |